In osteoarthritis (OA), these cells undergo pathological changes, shifting toward a catabolic phenotype that overproduces inflammatory cytokines (e.g., IL-1β, TNF-α) and matrix-degrading enzymes (e.g., MMPs, ADAMTS), accelerating cartilage breakdown (5–7). The gene discussed is TNF; the disease is osteoarthritis.